{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:04:24Z","timestamp":1789596264553,"version":"build-2803163510"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>The staging of testicular nonseminomatous germ cell tumors (NSGCTs) with lymphovascular invasion (LVI) of the spermatic cord in the absence of cord parenchymal involvement remains controversial. Our previous study showed that tumors with spermatic cord LVI present at a higher clinical stage than tumors with LVI confined to the testis (pT2). We compared NSGCTs with LVI of the spermatic cord without direct involvement of the spermatic cord soft tissues to pT3 tumors to help clarify the appropriate staging of this histologic finding. A retrospective, multi-institutional review was performed to identify cases of NSGCTs with LVI in the spermatic cord without soft tissue invasion of the cord. The clinical-pathologic findings were compared with NSGCTs with spermatic cord soft tissue invasion (pT3). We identified 38 pT2 NSGCTs with LVI in the spermatic cord without soft tissue invasion of the cord and 89 pT3 tumors. There were no significant differences in patient age, tumor size, or clinical stage at presentation between the 2 groups. There were no significant differences in dominant histologic subtype, rete testis invasion, hilar soft tissue invasion, or margin status. There were no significant differences in disease recurrence\/progression (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.63), recurrence\/progression after chemotherapy (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.35), or death (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.51) between patients with only spermatic cord LVI versus patients with cord soft tissue invasion. In patients with pT2 NSGCTs according to the current staging, LVI in the spermatic cord without cord soft tissue invasion is comparable with pT3 tumors in terms of clinical stage at presentation as well as disease recurrence and survival.<\/jats:p>","DOI":"10.1097\/pas.0000000000000917","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T18:24:46Z","timestamp":1500402286000},"page":"1397-1402","source":"Crossref","is-referenced-by-count":17,"title":["Do Nonseminomatous Germ Cell Tumors of the Testis With Lymphovascular Invasion of the Spermatic Cord Merit Staging as pT3?"],"prefix":"10.1097","volume":"41","author":[{"given":"Jennifer","family":"Gordetsky","sequence":"first","affiliation":[{"name":"Pathology"},{"name":"Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sanfrancesco","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Trevino","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Xu","sequence":"additional","affiliation":[{"name":"Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeboye","family":"Osunkoya","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang Q.","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Keck School of Medicine of University of Southern California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Sui","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Unger","sequence":"additional","affiliation":[{"name":"Department of Pathology, Lenox Hill Hospital, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Hashemi-Sadraei","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Albany","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Jorns","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Y.","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Rais-Bahrami","sequence":"additional","affiliation":[{"name":"Urology"},{"name":"Radiology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Ulbright","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad T.","family":"Idrees","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"811","DOI":"10.6004\/jnccn.2015.0094","article-title":"Follow-up management of patients with testicular cancer: a multidisciplinary consensus-based approach","volume":"13","author":"Beard","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cncr.30332","article-title":"Management trends for men with early stage nonseminomatous germ cell tumors of the testicle: an analysis of the National Cancer Database","volume":"123","author":"Weiner","year":"2017","journal-title":"Cancer"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMra1407550","article-title":"Testicular cancer\u2014discoveries and updates","volume":"371","author":"Hanna","year":"2014","journal-title":"N Engl J Med"},{"issue":"pt 1","key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.juro.2006.06.012","article-title":"Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?","volume":"176","author":"Divrik","year":"2006","journal-title":"J Urol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"J Clin Oncol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00345-016-1964-6","article-title":"Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors","volume":"35","author":"Gumus","year":"2017","journal-title":"World J Urol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00345-014-1454-7","article-title":"Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors","volume":"33","author":"Li","year":"2015","journal-title":"World J Urol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1200\/JCO.2012.47.6010","article-title":"Active surveillance is the preferred approach to clinical stage I testicular cancer","volume":"31","author":"Nichols","year":"2013","journal-title":"J Clin Oncol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.juro.2011.07.101","article-title":"Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer","volume":"186","author":"Williams","year":"2011","journal-title":"J Urol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/annonc\/mdv180","article-title":"A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion","volume":"26","author":"Lago-Hernandez","year":"2015","journal-title":"Ann Oncol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1002::AID-CNCR27>3.0.CO;2-A","article-title":"Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis","volume":"83","author":"Heidenreich","year":"1998","journal-title":"Cancer"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0090-4295(86)90329-8","article-title":"Predictors of recurrent clinical stage I nonseminomatous testicular cancer. A prospective clinicopathologic study","volume":"27","author":"Javadpour","year":"1986","journal-title":"Urology"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"824","DOI":"10.5858\/arpa.2016-0226-OA","article-title":"The significance of lymphovascular invasion of the spermatic cord in the absence of cord soft tissue invasion","volume":"141","author":"McCleskey","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jcp.2006.045732","article-title":"Staging and classification of testicular tumours: pitfalls from macroscopy to diagnosis","volume":"61","author":"Berney","year":"2008","journal-title":"J Clin Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.semdp.2011.10.001","article-title":"Practical issues and pitfalls in staging tumors of the genitourinary tract","volume":"29","author":"Osunkoya","year":"2012","journal-title":"Semin Diagn Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/his.12657","article-title":"Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists","volume":"67","author":"Berney","year":"2015","journal-title":"Histopathology"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5858\/1999-123-0014-PFTEOS","article-title":"Protocol for the examination of specimens from patients with malignant germ cell and sex cord-stromal tumors of the testis, exclusive of paratesticular malignancies: a basis for checklists. Cancer Committee, College of American Pathologists","volume":"123","author":"Ulbright","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/modpathol.2012.189","article-title":"Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors","volume":"26","author":"Yilmaz","year":"2013","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201710000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:26:46Z","timestamp":1695421606000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201710000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000917","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}